Stocks were flat after investors mulled over a less-than-encouraging report on consumer sentiment and a surge in earnings for General Electric
The US Consumer Sentiment Index fell from 72.9 in the previous month to 71.3, with many responders saying they were rattled by the fiscal cliff debacle. It was well below economists’ consensus of 75. Yesterday after market close, the Federal Reserve announced that its balance sheet grew to a record size, which concerned Federal Reserve Bank of Atlanta President Dennis Lockhart.
(INDEXDJX:DJI) edged down 0.14% to 13576.42. The S&P 500
(INDEXSP:.INX) opened at 1480.06 and fell 0.28% to 1476.19. The Nasdaq
(INDEXNASDAQ:.IXIC) went down 0.49% to 3120.41.
The oilfield services company Schlumberger Ltd.
(NYSE:SLB) increased its dividend by 13.6%. Schlumberger's stock edged up 2.98% to $75.56.
(NASDAQ:OSIS) went up 5.01% to $71.04 after the company announced that it will stop software development for body scanning machines used in US airports.
(NYSE:MS) enjoyed a fourth-quarter profit of $507 million and earnings per share of $0.45, beating the consensus by $0.18. Its stock went up 7.52% to $22.31.
General Electric's fourth-quarter earnings rose 7.5%, as a result of growth in developing economies. Shares opened at $21.90 and rose 3.01% to $21.94.
(NYSE:STI) earnings per share increased from $0.13 to $0.65 year over year. Shares were down 2.50% at $28.83.
(NYSE:SNE) announced it will sell its US headquarters in New York for $1 billion. The stock went up 4.95% to $12.50.
(NASDAQ:INTC) forecast its fourth-quarter revenue to be below analyst expectations, sending shares down 6.48%.
(NYSE:COF) took a beating after its fourth-quarter earnings disappointed analysts. Its stock was downgraded by Janney Capital Markets from Buy to Neutral” The stock fell hard to $56.33, down 8.31%.
(NYSE:AXP) is still reeling from weak fourth-quarter earnings. Its net income declined 47%. Stock fell 2.60% to $59.16.
(NASDAQ:FB) dipped 1.39% from $30.38 to $29.71.
The US Food and Drug Administration granted approval for NuPathe's
(NASDAQ:PATH) migraine patch Zecuity. The stock went up
8.15% to $3.59.
No positions in stocks mentioned.